Nifty Midcap 100 59385.15 (0.27)
Nifty 50 25637.8 (0.35)
Nifty Bank 57443.9 (0.41)
Nifty IT 38822.95 (-0.44)
Nifty Pharma 21928.6 (0.55)
Nifty Smallcap 100 18976.8 (0.91)
Nifty Next 50 68712.4 (0.61)
SENSEX 84058.9 (0.36)
NIKKEI 225 40150.79 (1.43)
HANG SENG 24284.15 (-0.17)
S&P 6232.75 (0.41)
BSE Code : 524404 | NSE Symbol : MARKSANS | ISIN : INE750C01026 | Industry : Pharmaceuticals |
Hot Pursuit 19-Jun-2025 (10:04) Marksans Pharma’s UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA
Hot Pursuit 30-May-2025 (09:33) Marksans Pharma gets regulatory nod for marketing type-2 diabetes medication in UK
Corporate News 30-May-2025 (09:13) Relonchem receives marketing authorization for Metformin Hydrochloride 500mg/ 5 ml Oral Solution in UK
Corporate News 20-May-2025 (12:49) Board of Marksans Pharma recommends final dividend
Results 20-May-2025 (07:46) Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others